Form 8-K - Current report:
SEC Accession No. 0001193125-21-160579
Filing Date
2021-05-13
Accepted
2021-05-13 16:38:47
Documents
21
Period of Report
2021-05-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d481425d8k.htm   iXBRL 8-K 49634
2 EX-4.1 d481425dex41.htm EX-4.1 664180
3 EX-10.1 d481425dex101.htm EX-10.1 196899
4 EX-99.1 d481425dex991.htm EX-99.1 11289
5 EX-99.2 d481425dex992.htm EX-99.2 14166
9 GRAPHIC g481425g0513125319034.jpg GRAPHIC 3782
10 GRAPHIC g481425g0513125320284.jpg GRAPHIC 4668
11 GRAPHIC g481425g0513125321301.jpg GRAPHIC 4508
12 GRAPHIC g481425gra081.jpg GRAPHIC 10154
13 GRAPHIC g481425sp084.jpg GRAPHIC 10569
  Complete submission text file 0001193125-21-160579.txt   1293250

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA dvax-20210510.xsd EX-101.SCH 3067
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE dvax-20210510_lab.xml EX-101.LAB 18139
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dvax-20210510_pre.xml EX-101.PRE 11406
14 EXTRACTED XBRL INSTANCE DOCUMENT d481425d8k_htm.xml XML 3398
Mailing Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 21920246
SIC: 2834 Pharmaceutical Preparations